Chen Y - Search Results

1

Mechanistic Insight into the Enhanced Anti-Pulmonary Hypertension Efficacy of Wogonin Co-Amorphous.

Xie Z, Chen Y, Xie J, Lei Y, Jia C, Liang Y, Wang H, Huang J. Xie Z, et al. Among authors: chen y. Pharmaceutics. 2025 May 30;17(6):724. doi: 10.3390/pharmaceutics17060724. Pharmaceutics. 2025. PMID: 40574037 Free PMC article.

2

Mechanistic investigation of wogonin in delaying the progression of endothelial mesenchymal transition by targeting the TGF-β1 pathway in pulmonary hypertension.

Wang X, Cui L, Wang Y, Zeng Z, Wang H, Tian L, Guo J, Chen Y. Wang X, et al. Among authors: chen y. Eur J Pharmacol. 2024 Sep 5;978:176786. doi: 10.1016/j.ejphar.2024.176786. Epub 2024 Jun 27. Eur J Pharmacol. 2024. PMID: 38942264

3

Natural Products for the Treatment of Pulmonary Hypertension: Mechanism, Progress, and Future Opportunities.

Zeng Z, Wang X, Cui L, Wang H, Guo J, Chen Y. Zeng Z, et al. Among authors: chen y. Curr Issues Mol Biol. 2023 Mar 13;45(3):2351-2371. doi: 10.3390/cimb45030152. Curr Issues Mol Biol. 2023. PMID: 36975522 Free PMC article. Review.

4

Network pharmacology provides new insights into the mechanism of traditional Chinese medicine and natural products used to treat pulmonary hypertension.

Wang X, Wang Y, Yuan T, Wang H, Zeng Z, Tian L, Cui L, Guo J, Chen Y. Wang X, et al. Among authors: chen y. Phytomedicine. 2024 Dec;135:156062. doi: 10.1016/j.phymed.2024.156062. Epub 2024 Sep 16. Phytomedicine. 2024. PMID: 39305743 Review.

5

Role of Xuefu Zhuyu decoction in improving pulmonary vascular remodeling by inhibiting endothelial-to-mesenchymal transition.

Zeng Z, Wang X, Wang H, Tian L, Cui L, Guo J, Chen Y. Zeng Z, et al. Among authors: chen y. Vascul Pharmacol. 2025 Mar;158:107467. doi: 10.1016/j.vph.2025.107467. Epub 2025 Jan 31. Vascul Pharmacol. 2025. PMID: 39894425

6

Mechanistic and therapeutic perspectives of baicalin and baicalein on pulmonary hypertension: A comprehensive review.

Cui L, Yuan T, Zeng Z, Liu D, Liu C, Guo J, Chen Y. Cui L, et al. Among authors: chen y. Biomed Pharmacother. 2022 Jul;151:113191. doi: 10.1016/j.biopha.2022.113191. Epub 2022 May 25. Biomed Pharmacother. 2022. PMID: 35643068 Free article. Review.

7

Deciphering the Mechanism of Wogonin, a Natural Flavonoid, on the Proliferation of Pulmonary Arterial Smooth Muscle Cells by Integrating Network Pharmacology and In Vitro Validation.

Cui L, Zeng Z, Wang X, Yuan T, Wang C, Liu D, Guo J, Chen Y. Cui L, et al. Among authors: chen y. Curr Issues Mol Biol. 2023 Jan 8;45(1):555-570. doi: 10.3390/cimb45010037. Curr Issues Mol Biol. 2023. PMID: 36661523 Free PMC article.

8

Activation of Nrf2 Attenuates Pulmonary Vascular Remodeling via Inhibiting Endothelial-to-Mesenchymal Transition: an Insight from a Plant Polyphenol.

Chen Y, Yuan T, Zhang H, Yan Y, Wang D, Fang L, Lu Y, Du G. Chen Y, et al. Int J Biol Sci. 2017 Sep 3;13(8):1067-1081. doi: 10.7150/ijbs.20316. eCollection 2017. Int J Biol Sci. 2017. PMID: 28924387 Free PMC article.

9

Systematic analysis of molecular mechanism of resveratrol for treating pulmonary hypertension based on network pharmacology technology.

Chen Y, Yuan T, Chen D, Liu S, Guo J, Fang L, Du G. Chen Y, et al. Among authors: chen d. Eur J Pharmacol. 2020 Dec 5;888:173466. doi: 10.1016/j.ejphar.2020.173466. Epub 2020 Aug 14. Eur J Pharmacol. 2020. PMID: 32798507

10

Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective.

Wang RR, Yuan TY, Wang JM, Chen YC, Zhao JL, Li MT, Fang LH, Du GH. Wang RR, et al. Pharmacol Res. 2022 Jun;180:106238. doi: 10.1016/j.phrs.2022.106238. Epub 2022 Apr 30. Pharmacol Res. 2022. PMID: 35504356 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191,431 results

Search Page

Filters